In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption

Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester and triglyceride between HDL and apoB-containing lipoproteins. Anacetrapib (ANA), a reversible inhibitor of CETP, raises HDL cholesterol and lowers LDL cholesterol in dyslipidemic patients. We previously demonstrated that ANA incr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Sheng-Ping, Daniels, Erin, Chen, Ying, Castro-Perez, Jose, Zhou, Haihong, Akinsanya, Karen O., Previs, Stephen F., Roddy, Thomas P., Johns, Douglas G.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2013
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3770098/
https://ncbi.nlm.nih.gov/pubmed/23898048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M041541
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars